PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 17–17 | Cite as

High costs of MS in Brazil due to disease-modifying therapies

Clinical study


  1. Diniz IM et al. The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil. PLOS One : 21 Jun 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations